Drug Discount Agreements for Various Active Substances (Open-House)
Original notice title
Germany – Pharmaceutical products – Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...
No documented procurement documents analyzed; may contain additional obligations not covered in notice.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications
Overview
Moderate opportunityKey Facts
- Supplies contract
- 1 lot
- Duration until Aug 2027
- Supply of pharmaceutical products (discount agreements) for seven active substances: Budesonide (oral 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, Umeclidinium bromide.
- Open-house model: any eligible pharmaceutical entrepreneur can join at any time during the contract period.
Show full summary
The tender is an open-house procedure for drug discount agreements (Rabattverträge) under §130a Abs. 8 SGB V for seven active substances: Budesonide (oral, 4mg), Eltrombopag, Fluorouracil (cream), Mebeverine, Nilotinib, Rotigotine, and Umeclidinium bromide. The buyer is AOK NordWest. The procedure is not a public procurement under EU directives (per EuGH C-410/14) but published voluntarily. The contract duration is up to 24 months starting 01.09.2025. All eligible pharmaceutical entrepreneurs can join at any time. No estimated value or award criteria are specified. Electronic submission is not allowed; applications are via email. The deadline for submission is 24.06.2027, 23:59 (but continuous accession is possible).
Risks
Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...
No documented procurement documents analyzed; may contain additional obligations not covered in notice.
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
Technical
- Must be a pharmaceutical entrepreneur as defined in §4 Abs. 18 AMG for the offered medicinal products, throughout the contract duration.
- Application via email to [email protected].
Administrative
- Uniform contract conditions; no individual negotiations.
Requirements may be incomplete.
Buyer
Location
Dortmund, DEU
Website
Identifier
DE124159739
Activity
Health
Lots (1)
LOT-0001
Drug Discount Agreements for Various Active Substances (Open-House)
All eligible pharmaceutical entrepreneurs can conclude discount agreements for the listed active substances under uniform conditions. The contract runs max. 24 months from 01.09.2025. There is no exclusivity; the buyer may later award exclusive contracts that suspend these agreements.
Location
Duration
Category
Deadline
Award details
Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V über die genannten Wirkstoffe/Wirkstoffkombinationen angeboten. Der früheste Vertragsbeginn ist der 01.09.2025. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate.
Value note
Show original TED data
Original lot title
Arzneimittel-Rabattverträge ab 01.09.2025 zu diversen Wirkstoffen im Rahmen eines Open-House-Verfahrens
Original TED description
Unter Vorgabe einheitlicher Vertragskonditionen sowie eines einheitlichen Zugangsverfahrens wird allen geeigneten und interessierten pharmazeutischen Unternehmen oder Gemeinschaften pharmazeutischer Unternehmen der Abschluss von Rabattverträgen nach § 130a Abs. 8 SGB V über die genannten Wirkstoffe/Wirkstoffkombinationen angeboten. Der früheste Vertragsbeginn ist der 01.09.2025. Davon ausgehend beträgt die Vertragslaufzeit maximal 24 Monate.
Procurement Details
- Publication date
- 17 Jul 2025
- Languages
- German
Reference metadata
- Legal basis
- 32014L0024
Reference IDs
- Tender ID
- 470057-2025
Documents (1)
Similar tenders
Germany – Site preparation work – VE111 Baustelleneinrichtung (119VM514 / Kronsh,SanDstBw,Ersatzneub. ZInstSanBw)
Poland – Advertising and marketing services – Zaplanowanie i realizacja kampanii Ministerstwa Finansów z zakresu działalności resortu finansów
France – Insurance services – Prestations de services d'assurance pour groupement le groupement hospitalier de territoire Yvelines Nord
Finland – Architectural, construction, engineering and inspection services – Tietomallikoordinaattori-, inventointimittaus- ja mallinnuspalvelujen puitejärjestely 2026-2028 (2028-2030)
Greece – Cultural event organisation services – ΛΕΙΤΟΥΡΓΙΑ ΤΟΥ ΘΕΑΤΡΟΥ ΟΛΥΜΠΙΑ ΜΑΡΙΑ ΚΑΛΛΑΣ ΜΕ ΕΞΕΙΔΙΚΕΥΜΕΝΟ ΠΡΟΣΩΠΙΚΟ
Spain – Architectural, construction, engineering and inspection services – Redacción del Proyecto Básico y de Ejecución, Redacción del Estudio de Seguridad y Salud y Dirección de Obra para la construcción del I.E.S. Nº 1 de 12+0 uds. (Fase 1) en la urbanización El Bosque de Pioz (Guadalajara).
Opportunity Score
Why this score?
Opportunity
50 / 100
Complexity
20 / 100
Risk factors
Buyer retains right to award exclusive contracts later, which will suspend these open-house agreements. Typically 8-10...
No documented procurement documents analyzed; may contain additional obligations not covered in notice.
Deep Portfolio Analysis
Uses:
- Description
- Industries & Services
- Capabilities
- Market & Experience
- Certifications